From: Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection
A) Patients with incident infection (n = 527) | ||||
---|---|---|---|---|
ZPHI patients | HIV notifications | |||
Number | 144 | 383 | ||
Male (n, %) | 129 | (89.6) | 332 | (86.7) |
Female (n, %) | 15 | (10.4) | 51 | (13.3) |
Transmission risk (n, %) | ||||
MSM | 102 | (70.8) | 242 | (63.2) |
HET | 37 | (25.7) | 102 | (26.6) |
IVDU | 4 | (2.8) | 17 | (4.4) |
OTH | 1 | (0.7) | 0 | (0) |
Unknown | 0 | (0) | 22 | (5.7) |
Age (median, IQR) | 36 | (30 - 42) | 35 | (28 - 43) |
Months of infection (median, IQR) | 1.59 | (1.05 - 2.73) | 1.04 | (0.33 - 3.0) |
HIV-1 RNA, (log [copies/mL]), IQR | 5.1 | (4.5 - 5.8) | 5.2 | (4.5 - 6.1) |
CD4+ T cell count, cells/μL (median, IQR) | 372 | (270 - 552) | n.a. | |
B) Patients with older infection (n = 740) | ||||
SHCS patients* | HIV notifications | |||
Number | 412 | 328 | ||
Male (n, %) | 205 | (49.8) | 231 | (70.4) |
Female (n, %) | 207 | (50.2) | 97 | (29.6) |
Transmission risk (n, %) | ||||
MSM | 54 | (13.1) | 90 | (27.4) |
HET | 283 | (68.7) | 194 | (59.1) |
IVDU | 48 | (11.6) | 16 | (4.9) |
OTH | 24 | (6.6) | 6 | (1.8) |
Unknown | 0 | (0) | 21 | (6.4) |
Age (median, IQR) | 35 | (30 - 41) | 44 | (34 - 53) |
Days of infection (median, IQR) | n.a. | n.a. | n.a. | n.a. |
HIV-1 RNA, (log [copies/mL]), IQR | 3.9 | (2.9 - 4.7) | 5.16 | (4.8 - 5.6) |
CD4+ T cell count, cells/μL (median, IQR) | 350 | (208 - 544) | n.a. | |
Treatment status | ||||
Prior to ART | 190 | (46.1) | 328 | (100) |
Under ART | 222 | (53.9) | 0 | (0) |
C) Notifications with unknown duration of infection (n = 1374) | ||||
Number | 1374 | |||
Male (n, %) | 924 | (67.2) | ||
Female (n, %) | 423 | (30.8) | ||
Unknown | 27 | (2.0) | ||
Transmission risk (n, %) | ||||
MSM | 401 | (29.2) | ||
HET | 472 | (34.3) | ||
IVDU | 40 | (2.9) | ||
OTH | 8 | (0.6) | ||
Unknown | 453 | (33.0) | ||
Age (median, IQR) | 36 | (30 - 45) | ||
HIV-1 RNA, (log [copies/mL]), IQR | 4.8 | (4.1 - 5.4) |